Healthcare and Life Science
Addenbrooke’s to host live Channel 4 programme for Stand Up To Cancer 2025
A pioneering Channel 4 programme presented by Davina McCall will be broadcast live from Addenbrooke’s Hospital as part of this year’s Stand Up To Cancer 2025. ...
RxCelerate and Constructive Bio announce partnership to advance next-generation therapeutics
Combining Constructive Bio’s pioneering programmable biology platform with RxCelerate’s expert drug design and development capabilities to drive innovation in engineered biologics for challenging diseases. ...
Inside Nanjing’s Biopharma Valley: A new phase of China–UK innovation synergy
By EFEC, UK–China life Sciences Innovation Hub Initiative.
If everyone automates, who still thinks? AI agents & the future of marketing
AI agents are moving from helpers to autonomous operators, running campaigns, reallocating budgets, updating CRMs and posting content, shifting marketing from manual execution to automated systems. With autonomy comes risk: loss of brand control, data security exposure, GDPR issues, an...
Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s researchONE BioHub provides Scottish Brain Sciences with infrastructure and integrated support to scale operations and drive forward its pioneering neurological researchEdinbu...
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership teamStephen will lead the Company’s scientific strategy, preclinical pipeline build and R&D organisationCambridge, UK,...
Trust emergency doctor wins second prestigious honour
An Addenbrooke’s doctor dedicated to shaping front line emergency care in the East of England – and influencing it worldwide - has won a second coveted award for his work. ...
Mystery of treatment-resistant childhood leukaemia uncovered
A new type of cancer cell that “warrants urgent investigation” has been discovered in childhood leukaemia, and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give hope to children and families worldwide. ...
Sanger scientists receive major grant to study rise of early onset colorectal cancer
Wellcome Sanger Institute researchers, Professor Sir Mike Stratton and Dr Trevor Lawley, together with Dr Paul Brennan of the International Agency for Research on Cancer (IARC) have been awarded a significant grant, enabling their team to investigate the causes of early onset colorectal...
Arecor enhances IP coverage for AT278 and Oral Delivery Technology
Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, provides an update on the broadening of its IP position. ...